297 related articles for article (PubMed ID: 25286120)
21. Differential regulation of transforming growth factor beta signaling pathways by Notch in human endothelial cells.
Fu Y; Chang A; Chang L; Niessen K; Eapen S; Setiadi A; Karsan A
J Biol Chem; 2009 Jul; 284(29):19452-62. PubMed ID: 19473993
[TBL] [Abstract][Full Text] [Related]
22. Smad2/Smad3 in endothelium is indispensable for vascular stability via S1PR1 and N-cadherin expressions.
Itoh F; Itoh S; Adachi T; Ichikawa K; Matsumura Y; Takagi T; Festing M; Watanabe T; Weinstein M; Karlsson S; Kato M
Blood; 2012 May; 119(22):5320-8. PubMed ID: 22498737
[TBL] [Abstract][Full Text] [Related]
23. Expression of nodal, lefty-a, and lefty-B in undifferentiated human embryonic stem cells requires activation of Smad2/3.
Besser D
J Biol Chem; 2004 Oct; 279(43):45076-84. PubMed ID: 15308665
[TBL] [Abstract][Full Text] [Related]
24. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
25. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
[TBL] [Abstract][Full Text] [Related]
26. Antitumor activity of ALK1 in pancreatic carcinoma cells.
Ungefroren H; Schniewind B; Groth S; Chen WB; Müerköster SS; Kalthoff H; Fändrich F
Int J Cancer; 2007 Apr; 120(8):1641-51. PubMed ID: 17230504
[TBL] [Abstract][Full Text] [Related]
27. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta.
Feng XH; Lin X; Derynck R
EMBO J; 2000 Oct; 19(19):5178-93. PubMed ID: 11013220
[TBL] [Abstract][Full Text] [Related]
28. TGF-beta and Smad3 signaling link inflammation to chronic fibrogenesis.
Bonniaud P; Margetts PJ; Ask K; Flanders K; Gauldie J; Kolb M
J Immunol; 2005 Oct; 175(8):5390-5. PubMed ID: 16210645
[TBL] [Abstract][Full Text] [Related]
29. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
[TBL] [Abstract][Full Text] [Related]
30. Cell-specificity of transforming growth factor-beta response is dictated by receptor bioavailability.
Suszko MI; Woodruff TK
J Mol Endocrinol; 2006 Jun; 36(3):591-600. PubMed ID: 16720726
[TBL] [Abstract][Full Text] [Related]
31. Kaurenoic acid activates TGF-β signaling.
Kim KH; Han JW; Jung SK; Park BJ; Han CW; Joo M
Phytomedicine; 2017 Aug; 32():8-14. PubMed ID: 28732811
[TBL] [Abstract][Full Text] [Related]
32. Combinatorial actions of Tgfβ and Activin ligands promote oligodendrocyte development and CNS myelination.
Dutta DJ; Zameer A; Mariani JN; Zhang J; Asp L; Huynh J; Mahase S; Laitman BM; Argaw AT; Mitiku N; Urbanski M; Melendez-Vasquez CV; Casaccia P; Hayot F; Bottinger EP; Brown CW; John GR
Development; 2014 Jun; 141(12):2414-28. PubMed ID: 24917498
[TBL] [Abstract][Full Text] [Related]
33. SMAD pathway mediation of BDNF and TGF beta 2 regulation of proliferation and differentiation of hippocampal granule neurons.
Lu J; Wu Y; Sousa N; Almeida OF
Development; 2005 Jul; 132(14):3231-42. PubMed ID: 15958511
[TBL] [Abstract][Full Text] [Related]
34. Interactions between the circadian clock and TGF-β signaling pathway in zebrafish.
Sloin HE; Ruggiero G; Rubinstein A; Smadja Storz S; Foulkes NS; Gothilf Y
PLoS One; 2018; 13(6):e0199777. PubMed ID: 29940038
[TBL] [Abstract][Full Text] [Related]
35. Fibroblast-specific TGF-β-Smad2/3 signaling underlies cardiac fibrosis.
Khalil H; Kanisicak O; Prasad V; Correll RN; Fu X; Schips T; Vagnozzi RJ; Liu R; Huynh T; Lee SJ; Karch J; Molkentin JD
J Clin Invest; 2017 Oct; 127(10):3770-3783. PubMed ID: 28891814
[TBL] [Abstract][Full Text] [Related]
36. The type III TGF-beta receptor signals through both Smad3 and the p38 MAP kinase pathways to contribute to inhibition of cell proliferation.
You HJ; Bruinsma MW; How T; Ostrander JH; Blobe GC
Carcinogenesis; 2007 Dec; 28(12):2491-500. PubMed ID: 17768179
[TBL] [Abstract][Full Text] [Related]
37. Smad3/AP-1 interactions control transcriptional responses to TGF-beta in a promoter-specific manner.
Verrecchia F; Vindevoghel L; Lechleider RJ; Uitto J; Roberts AB; Mauviel A
Oncogene; 2001 Jun; 20(26):3332-40. PubMed ID: 11423983
[TBL] [Abstract][Full Text] [Related]
38. TGF-beta activated Smad signalling leads to a Smad3-mediated down-regulation of DSPP in an odontoblast cell line.
He WX; Niu ZY; Zhao SL; Jin WL; Gao J; Smith AJ
Arch Oral Biol; 2004 Nov; 49(11):911-8. PubMed ID: 15353247
[TBL] [Abstract][Full Text] [Related]
39. Neuronal Transforming Growth Factor beta Signaling via SMAD3 Contributes to Pain in Animal Models of Chronic Pancreatitis.
Liu L; Zhu Y; Noë M; Li Q; Pasricha PJ
Gastroenterology; 2018 Jun; 154(8):2252-2265.e2. PubMed ID: 29505748
[TBL] [Abstract][Full Text] [Related]
40. TGF beta-1 downregulates DMP-1 and DSPP in odontoblasts.
Unterbrink A; O'Sullivan M; Chen S; MacDougall M
Connect Tissue Res; 2002; 43(2-3):354-8. PubMed ID: 12489180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
